csirt@kutim:~/threat-intel/cve/CVE-2022-49828

Katalog CVE

CVSS 5.5 · Medium EPSS 0,20%

Kerentanan Missing Release of Memory after Effective Lifetime pada linux kernel. Skor CVSS 3.1 5.5 (Medium) menurut NVD.

Deskripsi (NVD)

In the Linux kernel, the following vulnerability has been resolved: hugetlbfs: don't delete error page from pagecache This change is very similar to the change that was made for shmem [1], and it solves the same problem but for HugeTLBFS instead. Currently, when poison is found in a HugeTLB page, the page is removed from the page cache. That means that attempting to map or read that hugepage in the future will result in a new hugepage being allocated instead of notifying the user that the page was poisoned. As [1] states, this is effectively memory corruption. The fix is to leave the page in the page cache. If the user attempts to use a poisoned HugeTLB page with a syscall, the syscall will fail with EIO, the same error code that shmem uses. For attempts to map the page, the thread will get a BUS_MCEERR_AR SIGBUS. [1]: commit a76054266661 ("mm: shmem: don't truncate page if memory failure happens")

Rincian

Terbit di NVD
1 Mei 2025
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
5.5 (Medium), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-401: Missing Release of Memory after Effective Lifetime
EPSS (30 hari)
0,20% peluang dieksploitasi; lebih tinggi dari 9,0% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
linux linux kernel Semua versi sebelum 5.15.80
linux linux kernel Versi 5.16 hingga sebelum 6.0.10
linux linux kernel Versi 6.1 rc1
linux linux kernel Versi 6.1 rc2
linux linux kernel Versi 6.1 rc3
linux linux kernel Versi 6.1 rc4

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.